ANTINEOPLASTIC AGENTS
Clinical trials for ANTINEOPLASTIC AGENTS explained in plain language.
Never miss a new study
Get alerted when new ANTINEOPLASTIC AGENTS trials appear
Sign up with your email to follow new studies for ANTINEOPLASTIC AGENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kidney cancer: vorolanib under the microscope
Disease control Recruiting nowThis study looks at how well the drug vorolanib works for people with advanced kidney cancer that has spread or cannot be removed by surgery. It is for patients who need a second treatment after the first one stopped working. Researchers will track how long patients live without …
Matched conditions: ANTINEOPLASTIC AGENTS
Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Could one blood thinner be safer than two for older heart patients?
Disease control Recruiting nowThis study looks at whether using just one blood thinner (single antiplatelet therapy) is safer and as effective as using two (dual antiplatelet therapy) in older adults or those at high risk of bleeding who have had a heart procedure with a drug-coated balloon. About 576 partici…
Matched conditions: ANTINEOPLASTIC AGENTS
Phase: NA • Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Poop pills may soothe chemo tummy troubles in advanced cancer patients
Symptom relief Recruiting nowThis study looks at whether fecal microbiota transplantation (FMT) can reduce or prevent nausea, vomiting, and diarrhea caused by chemotherapy or targeted therapy in people with advanced gastrointestinal cancers. About 90 adults with stage IV cancer who are about to start their 4…
Matched conditions: ANTINEOPLASTIC AGENTS
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC